Catalyst Wire Dossier Catalyst Wire Dossier

SUBVENITE

LAMOTRIGINE · OWP Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SUBVENITE, covering 2025-09-16 to 2025-09-16. Get the full timeline:

Most recent: FDA Approved: SUBVENITE — Original Application (OWP Pharmaceuticals, Inc.)

See pricing